Svenska Handelsbanken’s Pfizer PFE Stock Holding History

Svenska Handelsbanken’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,582	Closed	-$636K	–	55
2017 Q1	$636K	Buy	19,582 +1,317	+7%	+$41.5K	0.85%	47
2016 Q4	$563K	Buy	+18,265	New	+$558K	0.03%	48
2016 Q3	–	Sell	-1,476,372	Closed	-$49.3M	–	109
2016 Q2	$49.3M	Buy	+1,476,372	New	+$47.1M	3.02%	13
2016 Q1	–	Sell	-4,901,872	Closed	-$150M	–	110
2015 Q4	$150M	Buy	+4,901,872	New	+$154M	15.15%	1

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Svenska Handelsbanken's PFE Position: Q2 2017 in Review

Svenska Handelsbanken sold out of Pfizer (PFE) in Q2 2017, closing a stake of 19,582 shares — an estimated $636K sold.

Svenska Handelsbanken first reported a position in PFE in Q4 2015 and held it in 4 quarters. The position peaked at $150M in Q4 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Svenska Handelsbanken reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Svenska Handelsbanken sold 19,582 Pfizer shares in Q2 2017, an estimated $636K.
Svenska Handelsbanken first reported a position in Pfizer in Q4 2015 and held it in 4 quarters.
Svenska Handelsbanken's Pfizer position peaked at $150M in Q4 2015.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Svenska Handelsbanken's 13F filing for Q2 2017, filed 8 Aug 2017.